AAMST is an all-in-one multiplex diagnostics system. It fully automates conventional laboratory-based PCR processes through 3 major elements: an analytical machine, a microfluidic reagent cartridge and a software. Pre-handling is minimal as it automatically runs extraction, reagent dispensing, nucleic acid amplification, signal detection, and analysis. The design is a combination of engineering, biochemistry, and production knowhow, delivering a high-quality diagnostic system at an affordable cost. Innovative amplification methods and proprietary primer design enable simultaneous 42-plex multiplex detection while maintaining superior sensitivity and specificity. Being showcased in the 7th edition of this WHO Compendium signified that AAMST’s affordable cost and comprehensiveness will fit well into different scenarios including LMICs.

According to WHO, “the Compendium serves as a catalyst for increased interaction among stakeholders—ministries of health, procurement officers, donors, developers, biomedical engineers, clinicians, and users. By providing evidence-based assessments and relevant information, it aims to drive use of innovative health technology and expand global access, particularly for low-resource settings for populations in need.”

The EVDL team will continue to strive for excellence and push Diagnosis beyond Boundaries!

Read More：https://www.who.int/publications/i/item/9789240095212